Stephen J. Forman
2022
In 2022, Stephen J. Forman earned a total compensation of $85.8K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 81% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $22,500 |
| Total | $85,840 |
Forman received $63.3K in option awards, accounting for 74% of the total pay in 2022.
Forman also received $22.5K in other compensation.
Rankings
In 2022, Stephen J. Forman's compensation ranked 5,563rd out of 5,690 executives tracked by ExecPay. In other words, Forman earned more than 2.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,563 out of 5,690 | 2nd |
Division Manufacturing | 3,032 out of 3,095 | 2nd |
Major group Chemicals And Allied Products | 1,381 out of 1,406 | 2nd |
Industry group Drugs | 1,288 out of 1,307 | 2nd |
Industry Pharmaceutical Preparations | 933 out of 949 | 2nd |
Source: SEC filing on November 4, 2024.
Forman's colleagues
We found six more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS